Compare MIND & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIND | CPHI |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.0M | 46.5M |
| IPO Year | 1997 | 2008 |
| Metric | MIND | CPHI |
|---|---|---|
| Price | $4.53 | $0.98 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 88.8K | ★ 571.2K |
| Earning Date | 04-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,675,000.00 | $4,144,268.00 |
| Revenue This Year | $23.31 | N/A |
| Revenue Next Year | $1.01 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.47 | $0.38 |
| 52 Week High | $14.50 | $19.19 |
| Indicator | MIND | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 36.00 | 46.90 |
| Support Level | N/A | $0.54 |
| Resistance Level | $5.46 | $1.43 |
| Average True Range (ATR) | 0.28 | 0.09 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 4.44 | 5.01 |
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.